Argenx
ARGX
#980
Rank
$16.75 B
Marketcap
$308.98
Share price
-0.86%
Change (1 day)
13.47%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Market capitalization of Argenx (ARGX)

Market cap: $16.75 Billion

As of May 2022 Argenx has a market cap of $16.75 Billion. This makes Argenx the world's 980th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Argenx from 2014 to 2022

Year Market cap Change
2022$17.86 B-2.87%
2021$18.39 B31.15%
2020$14.02 B103.85%
2019$6.87 B96.18%
2018$3.50 B74.88%
2017$2.00 B
2014$0.14 B

End of Day market cap according to different sources

On May 15th, 2022 the market cap of Argenx was reported to be:

$16.70 Billion
by Iex Cloud
$17.86 Billion
by CompaniesMarketCap
$16.90 Billion
by Nasdaq
$16.24 Billion
by Yahoo Finance